Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary culturesVICENTINI, Carlo; FESTUCCIA, Claudio; GRAVINA, Giovanni Luca et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 3, pp 165-174, issn 0171-5216, 10 p.Article

Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell lineFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; ANGELUCCI, Adriano et al.Anticancer research. 2000, Vol 20, Num 6B, pp 4367-4371, issn 0250-7005Article

Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptorSCACCIANOCE, Eugenia; FESTUCCIA, Claudio; DONDI, Donatella et al.Oncology research. 2003, Vol 14, Num 2, pp 101-112, issn 0965-0407, 12 p.Article

In vitro and invivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinomaFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; MUZI, Paola et al.The Prostate. 2007, Vol 67, Num 12, pp 1255-1264, issn 0270-4137, 10 p.Article

Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cellsGRAVINA, Giovanni Luca; FESTUCCIA, Claudio; ANGELUCCI, Adriano et al.International journal of oncology. 2004, Vol 25, Num 1, pp 97-104, issn 1019-6439, 8 p.Article

Chronic AzacitidineTreatment Results in Differentiating Effects, Sensitizes Against Bicalutamide in Androgen-lndependent Prostate Cancer CellsLUCA GRAVINA, Giovanni; FESTUCCIA, Claudio; MILLIMAGGI, Danilo et al.The Prostate. 2008, Vol 68, Num 7, pp 793-801, issn 0270-4137, 9 p.Article

Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patientsFESTUCCIA, Claudio; LUCA GRAVINA, Giovanni; MUZI, Paola et al.Oncology reports. 2007, Vol 18, Num 5, pp 1321-1327, issn 1021-335X, 7 p.Article

Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samplesFESTUCCIA, Claudio; ANGELUCCI, Adriano; GRAVINA, Giovanni Luca et al.International journal of oncology. 2005, Vol 26, Num 5, pp 1353-1362, issn 1019-6439, 10 p.Article

Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cellsANGELUCCI, Adriano; FESTUCCIA, Claudio; GRAVINA, Giovanni Luca et al.The Prostate. 2004, Vol 59, Num 2, pp 157-166, issn 0270-4137, 10 p.Article

Antitumor Effects of Carnertinib in Castration Resistant Prostate Cancer Models: A Comparative Study With ErlotinibGRAVINA, Giovanni Luca; MARAMPON, Francesco; PICCOLELLA, Margherita et al.The Prostate. 2011, Vol 71, Num 14, pp 1481-1491, issn 0270-4137, 11 p.Article

Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer ModelsGRAVINA, Giovanni Luca; MARAMPON, Francesco; JANNINI, Emmanuele A et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 12, pp 4550-4561, issn 0013-7227, 12 p.Article

Hypofractionated radical radiotherapy in elderly patients with medically inoperable stage I―II non-small-cell lung cancerBONFILI, Pierluigi; DI STASO, Mario; GRAVINA, Giovanni Lucas et al.Lung cancer. 2010, Vol 67, Num 1, pp 81-85, issn 0169-5002, 5 p.Article

Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancerLUCA GRAVINA, Giovanni; BIORDI, Leda; MARTELLA, Francesco et al.International journal of oncology. 2009, Vol 35, Num 5, pp 1133-1139, issn 1019-6439, 7 p.Article

Effects of Dutasteride on Prostate Carcinoma Primary Cultures : A Comparative Study With Finasteride and MK386FESTUCCIA, Claudio; LUCA GRAVINA, Giovanni; MUZI, Paola et al.The Journal of urology. 2008, Vol 180, Num 1, pp 367-372, issn 0022-5347, 6 p.Article

Late morbidity and oncological outcome after radical hypofractionated radiotherapy in men with prostate cancerDI STASO, Mario; BONFILI, Pierluigi; TOMBOLINI, Vincenzo et al.BJU international (Papier). 2010, Vol 106, Num 10, pp 1458-1462, issn 1464-4096, 5 p.Article

Her2 Crosstalks WithTrkA in a Subset of Prostate Cancer Cells : Rationale for a Guided Dual TreatmentFESTUCCIA, Claudio; LUCA GRAVINA, Giovanni; MUZI, Paola et al.The Prostate. 2009, Vol 69, Num 4, pp 337-345, issn 0270-4137, 9 p.Article

Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cellsMILLIMAGGI, Danilo; FESTUCCIA, Claudio; ANGELUCCI, Adriano et al.International journal of oncology. 2006, Vol 28, Num 4, pp 909-914, issn 1019-6439, 6 p.Article

Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitroFESTUCCIA, Claudio; MUZI, Paola; GRAVINA, Giovanni Luca et al.International journal of oncology. 2006, Vol 30, Num 1, pp 193-200, issn 1019-6439, 8 p.Article

PPARγ-dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF)CIMINI, Annamaria; CRISTIANO, Loredana; COLAFARINA, Sabrina et al.International journal of cancer. 2005, Vol 117, Num 6, pp 923-933, issn 0020-7136, 11 p.Article

Ozarelix, a Fourth Generation GnRH Antagonist, Induces Apoptosis in Hormone Refractory Androgen Receptor Negative Prostate Cancer Cells Modulating Expression and Activity of Death ReceptorsFESTUCCIA, Claudio; DONDI, Donatella; PICCOLELLA, Margherita et al.The Prostate. 2010, Vol 70, Num 12, pp 1340-1349, issn 0270-4137, 10 p.Article

Bicalutamide Demonstrates Biologic Effectiveness in Prostate Cancer Cell Lines and Tumor Primary Cultures Irrespective of Her2/neu Expression LevelsLUCA GRAVINA, Giovanni; FESTUCCIA, Claudio; MILLIMAGGI, Danilo et al.Urology (Ridgewood, NJ). 2009, Vol 74, Num 2, pp 452-457, issn 0090-4295, 6 p.Article

Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cellsFESTUCCIA, Claudio; LUCA GRAVINA, Giovanni; D'ALESSANDRO, Anna Maria et al.International journal of oncology. 2008, Vol 33, Num 2, pp 381-388, issn 1019-6439, 8 p.Article

Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancerLUCA GRAVINA, Giovanni; FESTUCCIA, Claudio; PARADISO GALATIOTO, Giuseppe et al.Urology (Ridgewood, NJ). 2007, Vol 70, Num 4, pp 728-733, issn 0090-4295, 6 p.Article

Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsANGELUCCI, Adriano; SCHENONE, Silvia; GRAUINA, Giovanni Luca et al.European journal of cancer (1990). 2006, Vol 42, Num 16, pp 2838-2845, issn 0959-8049, 8 p.Article

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity : EGF-receptor inhibition may prevent tumor cell disseminationFESTUCCIA, Claudio; ANGELUCCI, Adriano; GRAVINA, Giovanni Luca et al.Thrombosis and haemostasis. 2005, Vol 93, Num 5, pp 964-975, issn 0340-6245, 12 p.Article